COVID-19 is catalyzing the adoption of teleneurology
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published April 1, 2020.
Article Versions
- Previous version (April 1, 2020 - 12:45).
- Previous version (April 3, 2020 - 07:33).
- Previous version (April 24, 2020 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Brad C. Klein, MD, MBA and
- Neil A. Busis, MD
- Brad C. Klein, MD, MBA and
NONE
NONE
(1) Allergan, (2) Amgen, (3) Biohaven, (4) Eagalet, (5) Eli Lilly, (6) Lundbeck, (7) Promius, (8) Teva, (9) US WorldMeds.
NONE
NONE
NONE
Abington Neurological Associates, Ltd., Chief Operating Officer, 12 years
(1) Allergan, (2) Amgen, (3) Biohaven, and (4) Promius
(1) Allergan, (2) Amgen, (3) Biohaven, (4) Eagalet, (5) Eli Lilly, (6) Lundbeck, (7) Promius, (8) Teva, (9) US WorldMeds.
Equity interest in AppsByDocs, LLC, makers of p-cog.
NONE
(1) Alder, (2) Allergan, and (3) Eli Lilly
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Neil A. Busis, MD
Alternate CPT Advisor for American Academy of Neurology on the CPT Advisory Committee. CPT is operated by the American Medical Association
NONE
Speaker at courses sponsored by the American Academy of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
Former Member of the American Academy of Neurology Board of Directors. Only travel expenses until April, 2017 were reimbursed.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From Abington Hospital (B.C.K.), Department of Neurology, Thomas Jefferson University, Philadelphia, PA; and Department of Neurology (N.A.B.), NYU Langone Health, New York.
- Correspondence
Dr. Klein bradcklein{at}gmail.com
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Author response: COVID-19 is catalyzing the adoption of teleneurology
- Brad C. Klein, Neurologist, Abington Hospital, Department of Neurology, Thomas Jefferson University
- Neil A. Busis, Neurologist, NYU Langone Health, Department of Neurology
Submitted April 21, 2020 - Reader response: COVID-19 is catalyzing the adoption of teleneurology
- Nitin K. Sethi, Associate Professor of Neurology, New York-Presbyterian Hospital, Weill Cornell Medical Center (New York City)
Submitted April 14, 2020
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.